The aim of the present investigation was to develop oral films of valdecoxib using Eudragit EPO and hydroxypropylmethylcellulose. Films of Eudragit EPO, hydroxypropylmethylcellulose and Eudragit EPO combined with hydroxypropylmethylcellulose were prepared by film casting method. Glycerol, menthol and aspartame were incorporated in the drug containing films as plasticizer, cooling agent and sweetener, respectively. The drug loading was 10 mg valdecoxib per 4 cm 2 of the film. The films were evaluated for hydration study, folding endurance and in vitro drug dissolution in the distilled water. The films containing both Eudragit EPO and hydroxypropylmethylcellulose films showed neutral surface pH when prepared using 0.1 N HCl as a solvent. Glycerol played a critical role in imparting flexibility to the film and improving the drug release from film. The bitter taste of the drug was masked by using aspartame and menthol accompanied by the synergistic effect of Eudragit and glycerol. Water uptake by films was found to be dependant both on the amount of Eudragit EPO and glycerol. The films containing the higher proportion of glycerol showed higher water uptake and faster drug release at all the sampling time in the in vitro dissolution test. Optimum plasticity was obtained using the required concentration of hydroxypropylmethylcellulose and glycerol. The study revealed that taste masked valdecoxib films can be developed by the selection of appropriate film former and by the use of auxiliary excipients.
Amongst the various routes of drug delivery, oral route Valdecoxib is a non-steroidal antiinflammatory drug that is the most preferred by patients and clinicians. A also exhibits analgesic and antipyretic activity by inhibiting renewed interest has been addressed to oral solid cyclooxygenase-2 isozyme [5] [6] . Drugs can be absorbed dosage forms designed for prompt availability of through oral mucosa into the systemic circulation 7, 8 . One therapeutic dose. Mouth dissolve products (tablets and of the major issues in use of oral films is taste masking films) may show greater patient acceptability and convenience. They can be taken with ease at any time by the patient without water 1, 2 . Oral film may be preferred over the mouth dissolve tablets in terms of flexibility and comfort 3 . In addition, they can also circumvent the sticky feeling in the oral cavity associated with oral gels. Moreover, the oral film is able to protect the wound surface, thus reduce pain and also could treat oral disease more effectively 4 . *For correspondence E-mail: mukeshgohel@rediffmail.com for the bitter drugs. Valdecoxib has bitter taste and hence taste masking would be the primary requirement for the development of oral film of valdecoxib. Most of the current orally used film making polymers are gums, chitosan, polyacrylic and cellulose derivatives [8] [9] [10] . Depending on the type of polymer used, films of different solubility characteristic can be produced. Eudragit EPO is used as a film former and is soluble in the acidic pH. Hydroxypropylmethylcellulose (HPMC) is a gelling, matrixing and film forming polymer. Depending on the molecular weight of HPMC the desired release of drug can be achieved. The main goal of the present investigation was to develop films consisting of Eudragit The film of the optimized batches (4 cm 2 ) was taken and was firmly folded through the middle. The number of folds, on the same crease, required to produce crack in the film was taken as a measure of plasticity.
chemicals and solvents were of analytical grade.
The Eudragit films were prepared by solvent casting method using 5, 10 and 15% w/v of Eudragit EPO in 10 milliliters of dichloromethane (DCM) or 0.1 N HCl as two different solvents. Glycerol and PEG 400 were evaluated as plasticizers in the ratio of 1:0.2 of dry polymer to dry plasticizer. The solutions were cast on plastic Petri dishes (9.8 cm diameter, 8 mm height). The films were dried in an oven at 45 0 for 24 h. After drying, the films were separated from the surface of petridish and stored in air tight plastic bags.
Aqueous HPMC solutions (1, 2 and 3% w/v) were used to prepare the HPMC film in the plastic petridish. Ten milliliters of the clear aqueous solution was used for casting films. The films were dried at 45 0 for 48 h. The dried films were stored in airtight plastic bags till further use.
Eudragit EPO and glycerol were dissolved in 10 ml 0.1 N HCl. To this solution, HPMC was added by sprinkling the powder in the agitated solution. Ten milliliters of clear homogenous solution was poured in the plastic petridish and the films were dried for 48 h at 45 0 in a hot air oven. The drug loaded films were prepared from the optimized batch by incorporating 190 mg of valdecoxib to achieve the dose of 10 mg per 4 cm 2 film. Tables 1 and Films containing 10 mg valdecoxib were used in the in vitro dissolution study. Dissolution study was conducted in modified USP XXIII apparatus (paddle over disk) at 100 rpm, using 1000 milliliters distilled water as a dissolution media. The temperature was maintained at 37±0.5 0 . Five milliliters samples were withdrawn at the regular intervals and analyzed by Hitachi U2000 double beam UV/Vis spectrophotometer at 245 nm. An equal amount of fresh dissolution media was replaced immediately after 1  2  3 1  2  3  1  2  3 1  2  3  1  2  3 1  2  3  1  2  3 1  2  3 2 display the composition of various films. The films containing both the film formers were stored in air tight plastic bags till further use.
Hydration study was conducted as described by Wong et al 11 . The hydration ratio of the batches V 1 to V 4 was determined gravimetrically. The film sample (1 cm 2 ) was weighed and placed on a preweighed stainless steel wire mesh with average sieve opening of 200 µm. The screen was then submerged in a petridish containing 20 ml distilled water. Increase in weight of the film was determined at regular time intervals until a constant weight was obtained. The hydration ratio of the film was www.ijpsonline.com withdrawal of the sample. The results are shown in fig. 2 . Preliminary studies were carried out to select suitable solvent and plasticizer. Eudragit EPO films were prepared either using dichloromethane (DCM) or 0.1 N HCl as a solvent. Plasticizers were added to improve the softness of the film and to assist easy detachment of the film from surface of the plastic petridish. Eudragit films formed using DCM as the solvent, could not be separated from the surface of petridish. Films of uniform thickness, good elasticity and clarity were obtained when 0.1 N HCl was used as a solvent. Eudragit EPO solution (10%w/v) The quantities shown above are in mg.
containing glycerol as plasticizer yielded superior film. Eudragit films prepared using PEG 400 as a plasticizer taste of a bitter drug 13 . Batch V2 ( Table 2 ) was was too soft and difficult to separate from the petridish.
prepared to study the effect of increased amount of HPMC films of moderate to low elasticity were formed Eudragit EPO and glycerol on taste masking. with 2% and 3% w/v solution. These films were easily However, there was no appreciable improvement in detachable and seldom needed any additional plasticizer, the taste masking. Addition of flavors and sweeteners though the elasticity was poor (folding endurance= 9).
is the simplest approach for taste masking. Menthol Water is as a plasticizer and solvent for HPMC.
when used as a flavoring agent not only suppresses the bitter taste but also provides anticaries and mild The combination film of Eudragit EPO and HPMC were anaesthetic effect. However, when used in lower level prepared (batches EH1 to EH5) to get desired film (1.9 mg), synergistic combination of aspartame and properties like ease in film separation and faster drug menthol were not effective in suppressing the bitter release. The film of batch EH1 was yellowish white in taste. Therefore, higher concentration of aspartame color and hazy in appearance. The amount of Eudragit and menthol were used in succeeding batches along EPO was reduced to promote clarity and flexibility. The with the increase in concentration of glycerol to aid in result shown in Table 1 reveals that the film of batch suppressing the bitterness and to act as a plasticizer. EH3 exhibited better clarity and elasticity. The film of Batches V3 and V4 showed improvement in taste Batch EH3 was selected for further study considering masking. clarity and elasticity.
From the comparative dissolution profile of batches V1 Five batches (V1 -V5) of drug containing films were and V2 as shown in fig. 2 , it can be observed that as the prepared. Valdecoxib was added to Eudragit EPO concentration of Eudragit EPO was increased, there was solution in 0.1 N HCl. A part of the acid was insignificant retardation in the drug release. Progressive neutralized due to basic nature of valdecoxib. The increase in the drug release was observed in batch V3 films prepared using 0.1 N HCl exhibited almost and V4. Therefore, it is concluded that glycerol not only neutral pH. As valdecoxib is present in salt form in contributed to sweetness but also acted as a solubility the film its solubility was appreciably increased enhancer. This was due to increased water uptake of the thereby promoting the faster release of the drug from the oral film. Taste masking of the bitter drug like valdecoxib was of foremost priority in designing oral formulations. Eudragit EPO had been used to mask the The quantities shown above are in mg.
film as a result of increase in concentration of glycerol as depicted in fig. 1 . About 75% of valdecoxib was released in 10 min and films of batch V4 masked the bitter taste of the drug. This batch showed hydration ratio of 4.1 indicating the rapid water uptake and hence faster drug release. Good elasticity can be assured from the folding endurance. It can be concluded that Eudragit EPO and HPMC can be used in concert to develop rapid dissolve taste masked film of valdecoxib. The film characteristics can be manipulated by making changes in the formulation. The film can be taken as such by patients or can be put into capsules. Further studies are required in selecting appropriate package for marketing.
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